These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 3420976)

  • 1. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment.
    Vodopija I; Sureau P; Smerdel S; Lafon M; Baklaić Z; Ljubicić M; Svjetlicić M
    Vaccine; 1988 Jun; 6(3):283-6. PubMed ID: 3420976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of PVRV and HDCV rabies vaccines as to immunity, reliability and protective value].
    Hacibektaşoğlu A; Inal A; Eyigün C; Barut A; Türkay FA
    Mikrobiyol Bul; 1992 Jan; 26(1):26-36. PubMed ID: 1574019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS
    Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified and economical intradermal regimen of purified chick embryo cell rabies vaccine for postexposure prophylaxis.
    Suntharasamai P; Chaiprasithikul P; Wasi C; Supanaranond W; Auewarakul P; Chanthavanich P; Supapochana A; Areeraksa S; Chittamas S; Jittapalapongsa S
    Vaccine; 1994 May; 12(6):508-12. PubMed ID: 8036824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure schedule.
    Vodopija I; Sureau P; Lafon M; Baklaic Z; Ljubicić M; Svjetlicić M; Smerdel S
    Vaccine; 1986 Dec; 4(4):245-8. PubMed ID: 3541428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to human diploid cell vaccine for rabies with and without human rabies immune globulin.
    Mertz GJ; Nelson KE; Vithayasai V; Makornkawkeyoon S; Rosanoff EI; Tint H; Wiktor TJ
    J Infect Dis; 1982 May; 145(5):720-7. PubMed ID: 7077095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
    Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
    Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The abbreviated 2-1-1 schedule of purified chick embryo cell rabies vaccination for rabies postexposure treatment.
    Wasi C; Chaiprasithikul P; Auewarakul P; Puthavathana P; Thongcharoen P; Trishnananda M
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):461-6. PubMed ID: 8160053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.
    Manning SE; Rupprecht CE; Fishbein D; Hanlon CA; Lumlertdacha B; Guerra M; Meltzer MI; Dhankhar P; Vaidya SA; Jenkins SR; Sun B; Hull HF;
    MMWR Recomm Rep; 2008 May; 57(RR-3):1-28. PubMed ID: 18496505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
    Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
    J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous human rabies immunoglobulin for post-exposure prophylaxis: serum rabies neutralizing antibody concentrations and side-effects.
    Aoki FY; Rubin ME; Friesen AD; Bowman JM; Saunders JR
    J Biol Stand; 1989 Jan; 17(1):91-104. PubMed ID: 2646301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rabies specific IgM- and IgG-antibody response in persons immunized with HDCS vaccine according to the Essen postexposure vaccination schedule (author's transl)].
    Thraenhart O; Kuwert EK
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):429-41. PubMed ID: 44937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices.
    Rupprecht CE; Briggs D; Brown CM; Franka R; Katz SL; Kerr HD; Lett SM; Levis R; Meltzer MI; Schaffner W; Cieslak PR;
    MMWR Recomm Rep; 2010 Mar; 59(RR-2):1-9. PubMed ID: 20300058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative immunogenicity of 2 antirabies vaccines in a 2-1-1 post-exposure vaccination schedule].
    Landry P; Lazzaro M; Darioli R
    Praxis (Bern 1994); 1998 Sep; 87(37):1177-9. PubMed ID: 9785997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a new chromatographically purified rabies vaccine in comparison to the human diploid cell vaccine.
    Arora A; Moeller L; Froeschle J
    J Travel Med; 2004; 11(4):195-9. PubMed ID: 15541220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of purified chick embryo cell anti-rabies vaccine in post-exposure treatment of animal bite cases.
    Bhardwaj M; Bhattacharya D; Chhabra M; Ichhpujani RL
    J Commun Dis; 2002 Mar; 34(1):40-2. PubMed ID: 12718340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-exposure immunization against rabies using Japanese rabies vaccine following the WHO recommended schedule.
    Yanagisawa N; Takayama N; Nakayama E; Mannen K; Suganuma A
    J Infect Chemother; 2010 Feb; 16(1):38-41. PubMed ID: 20063031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.